Pierre Lunel
CEO
General Manager Novasep Belgium
Merial
France
Biography
Novasep Belgium biopharmaceutical manufacturing solutions include bioprocess development and contract biomanufacturing services. Unique manufacturing capabilities and a track record for BSL3 pathogens, viruses and viral vectors (lentivirus, AAV, ADV, etc.) for gene therapy and vaccination, and experience in manufacturing monoclonal antibodies.
Research Interest
Novasep Belgium biopharmaceutical manufacturing solutions include bioprocess development and contract biomanufacturing services. Unique manufacturing capabilities and a track record for BSL3 pathogens, viruses and viral vectors (lentivirus, AAV, ADV, etc.) for gene therapy and vaccination, and experience in manufacturing monoclonal antibodies.
